众生药业：已有2个创新药项目获批上市 多个创新药项目处于临床试验阶段

Group 1 - The company has established a multi-mode positive cycle research and development ecosystem, focusing on self-research as the main approach and collaborative research as an effective supplement [1] - The company primarily targets metabolic diseases and respiratory system diseases [1] - Currently, the company has two innovative drug projects approved for market launch, with multiple innovative drug projects in clinical trial stages [1]